Odronextamab as First-Line Therapy in Follicular Lymphoma | Ruemu Birhiray, MD | #ASH24
Dr Rueme Birhiray discusses a new class of drug, bispecific antibodies, for patients with follicular lymphoma, specifically studies looking at odronextamab. Link to ASH playlist: https://healthtree.org/blood-cancer/u... ASH Abstract: Odronextamab Monotherapy in Previously Untreated Patients with High-Risk Follicular Lymphoma (FL): Results of the Safety Lead-in of the Phase 3 Olympia-1 Study #ASH24 #FollicularLymphoma #lymsm Follow HealthTree: https://linktr.ee/HealthTreeUniversity
▶︎
Promising Results for CAR-T Cell therapy for Follicular Lymphoma | Matthew Frank, MD, PhD | #ASH24
▶︎
TP53-Mutated AML & MDS: Why Clinical Trials Are Your Best Option | Dan Link, MD | #ASH24
▶︎
Allogeneic & Autologous Stem Cell Transplant for Follicular Lymphoma | Yasmina Serroukh, MD | #ASH24
▶︎
Non-Hodgkin Lymphoma: Symptoms & Treatment | Stanford
▶︎
Why Gen Z Filipinos Are Giving Up on Dating and Marriage | AB Explained
▶︎
Seniors No 1 Oncologist Reveals Foods to Starve Cancer Cells Naturally After 50! |Dr. William Li
▶︎
NERVOUS 12-Year-Old Who Can Sing Without Opening Her Mouth Earns Mel B's GOLDEN BUZZER!
▶︎
The French Do Not Care About Work
▶︎
Robotaxis coming to London pose threat to cabbies who memorize 25,000 streets to earn licenses
▶︎
AUTISTIN trifft HOCHSENSIBEL | Das Treffen
▶︎
How Russell Brand became a Christian influencer | The Global Story
▶︎
BTK Degrader Study Shows Promise for a New Class of CLL Therapies | Alexey Danilov MD PhD | #ASH2024
▶︎
Your immune system will kill cancer itself—WITHOUT chemotherapy or surgery: just ONE secret. Spon...
▶︎
More Net Zero madness from Miliband & harvest 2026 could be one of the best ever
▶︎
Wenn der Tod ein Anfang ist | Die Nordreportage | NDR
▶︎
Factors Influencing Enrollment in Hematologic Cancer Trials (2008-2023) | Rupayan Kundu, MD | #ASH24
▶︎
Stop Walking 10,000 Steps/Day (do this for 10 minutes instead)
▶︎
Wie Tech-Milliardär Peter Thiel die Apokalypse verhindern will | 3sat kulturzeit
▶︎
Adding Menin Inhibitors in Combination Therapy for AML Patients | Amir Fathi, MD | #ASH24
▶︎